Clinical trial
Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis
NCT00301002 · The Guenther Dermatology Research Centre, Other · Completed
Key facts
| NCT number | NCT00301002 |
|---|---|
| Title | Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis |
| Official title | A Pilot Open-Label Study to Evaluate the Safety and Observe the Effectiveness of 16 Weeks of Alefacept in Palmar Plantar Pustulosis (IST 92) |
| Lead sponsor | The Guenther Dermatology Research Centre, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis, Palmoplantaris Pustulosis, Pustular Psoriasis of Palms and Soles, Pustulosis Palmaris et Plantaris, Pustulosis of Palms and Soles |
| Intervention type | Drug |
| Interventions | Alefacept |
| Enrollment | 15 |
| Start date | Jun 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Mar 10, 2006 |
| Last update posted | Nov 23, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: